PharmacoEconomics & Outcomes News

, Volume 799, Issue 1, pp 32–32 | Cite as

Rapid-acting insulin analogue cost effective in Germany

Clinical study


  1. Valentine WJ, et al. Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation. Applied Health Economics and Health Policy : 10 Mar 2018. Available from: URL:

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations